Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Moore

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Biological Chemistry|April 15, 1992
The B cell-specific nuclear factor OTF-2 positively regulates transcription of the human class II transplantation gene, DRAN J Zeleznik-Le, Y Itoh-Lindstrom, J B Clarke, et al.
The British Journal of Dermatology|June 14, 2005
Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasisA K Murray, A L Herrick, T L Moore, et al.
The Journal of Rheumatology|November 1, 1991
Septic arthritis caused by Hemophilus influenza type B in a patient with HIV-1 infectionJ M Lawrence, T G Osborn, R Paro, et al.
The Journal of Rheumatology|April 1, 1985
Hidden and classical 19S IgM rheumatoid factor in a juvenile rheumatoid arthritis patientK Emancipator, T L Moore, R W Dorner, et al.
Arthritis and Rheumatism|January 1, 1986
Anticentriole antibody in a patient with progressive systemic sclerosisT G Osborn, J S Ryerse, N E Bauer, et al.
The Journal of Rheumatology|June 1, 1985
Complement-fixing ability and specificity of 19S IgM rheumatoid factors in patients with rheumatoid arthritisJ C Speiser, T L Moore, T D Weiss, et al.
Arthritis and Rheumatism|August 1, 1982
Frequencies of Epstein-Barr virus-inducible IgM anti-IgG B lymphocytes in normal children and children with juvenile rheumatoid arthritisS Fong, J J Miller, T L Moore, et al.
Clinical Therapeutics|November 1, 1989
Diflunisal versus naproxen in the management of rheumatoid arthritisT G Osborn, R L Parks, T L Moore, et al.
Seminars in Arthritis and Rheumatism|December 1, 1989
Heart disease in systemic sclerosisD L Janosik, T G Osborn, T L Moore, et al.
The British Journal of Dermatology|May 1, 2012
Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectasesA K Murray, T L Moore, H Richards, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Biological Chemistry|April 15, 1992
The B cell-specific nuclear factor OTF-2 positively regulates transcription of the human class II transplantation gene, DRAN J Zeleznik-Le, Y Itoh-Lindstrom, J B Clarke, et al.
The British Journal of Dermatology|June 14, 2005
Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasisA K Murray, A L Herrick, T L Moore, et al.
The Journal of Rheumatology|November 1, 1991
Septic arthritis caused by Hemophilus influenza type B in a patient with HIV-1 infectionJ M Lawrence, T G Osborn, R Paro, et al.
The Journal of Rheumatology|April 1, 1985
Hidden and classical 19S IgM rheumatoid factor in a juvenile rheumatoid arthritis patientK Emancipator, T L Moore, R W Dorner, et al.
Arthritis and Rheumatism|January 1, 1986
Anticentriole antibody in a patient with progressive systemic sclerosisT G Osborn, J S Ryerse, N E Bauer, et al.
The Journal of Rheumatology|June 1, 1985
Complement-fixing ability and specificity of 19S IgM rheumatoid factors in patients with rheumatoid arthritisJ C Speiser, T L Moore, T D Weiss, et al.
Arthritis and Rheumatism|August 1, 1982
Frequencies of Epstein-Barr virus-inducible IgM anti-IgG B lymphocytes in normal children and children with juvenile rheumatoid arthritisS Fong, J J Miller, T L Moore, et al.
Clinical Therapeutics|November 1, 1989
Diflunisal versus naproxen in the management of rheumatoid arthritisT G Osborn, R L Parks, T L Moore, et al.
Seminars in Arthritis and Rheumatism|December 1, 1989
Heart disease in systemic sclerosisD L Janosik, T G Osborn, T L Moore, et al.
The British Journal of Dermatology|May 1, 2012
Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectasesA K Murray, T L Moore, H Richards, et al.
Pageof 16